Christopher G. Hayes - Net Worth and Insider Trading
Christopher G. Hayes Net Worth
The estimated net worth of Christopher G. Hayes is at least $1 Million dollars as of 2024-05-25. Christopher G. Hayes is the Chief Legal Officer of Verrica Pharmaceuticals Inc and owns about 123,226 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $1 Million. Details can be seen in Christopher G. Hayes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher G. Hayes has not made any transactions after 2023-11-15 and currently still holds the listed stock(s).
Transaction Summary of Christopher G. Hayes
Christopher G. Hayes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher G. Hayes owns 1 companies in total, including Verrica Pharmaceuticals Inc (VRCA) .
Click here to see the complete history of Christopher G. Hayes’s form 4 insider trades.
Insider Ownership Summary of Christopher G. Hayes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc | 2023-11-15 | General Counsel |
Christopher G. Hayes Latest Holdings Summary
Christopher G. Hayes currently owns a total of 1 stock. Christopher G. Hayes owns 123,226 shares of Verrica Pharmaceuticals Inc (VRCA) as of November 15, 2023, with a value of $1 Million.
Latest Holdings of Christopher G. Hayes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc | 2023-11-15 | 123,226 | 8.56 | 1,054,815 |
Holding Weightings of Christopher G. Hayes
Christopher G. Hayes Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher G. Hayes has made a total of 4 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the sale of 33,699 shares on November 15, 2023, which brought Christopher G. Hayes around $99,075.
Insider Trading History of Christopher G. Hayes
- 1
Christopher G. Hayes Trading Performance
GuruFocus tracks the stock performance after each of Christopher G. Hayes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher G. Hayes is 11.92%. GuruFocus also compares Christopher G. Hayes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher G. Hayes within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher G. Hayes's insider trading performs compared to the benchmark.
Performance of Christopher G. Hayes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.85 | | | | | |
| Relative Return to S&P 500(%) | 14.83 | | | | | |
Christopher G. Hayes Ownership Network
Christopher G. Hayes Owned Company Details
What does Verrica Pharmaceuticals Inc do?
Who are the key executives at Verrica Pharmaceuticals Inc?
Christopher G. Hayes is the General Counsel of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , director & President and CEO Ted White , and Chief Commercial Officer Joe Bonaccorso .
Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary
Over the past 18 months, Christopher G. Hayes made 2 insider transaction in Verrica Pharmaceuticals Inc (VRCA) with a net sale of 67,488. Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net purchase of 2,060,199 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 84,376 shares made by Ted White , and a net sale of 71,108 shares made by Joe Bonaccorso .
In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 288,608 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,971,591 shares.
Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verrica Pharmaceuticals Inc Insider Transactions
Christopher G. Hayes Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher G. Hayes. You might contact Christopher G. Hayes via mailing address: C/o Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester Pa 19380.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
